Clinical Trials Browser

Phase 2 × Thymoma × Clear all

NCT03076554 2026-05-22

A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy

Phase 2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Thymoma

NCT03134118 2026-05-15

NIVOTHYM

Phase 2 Active not recruiting

Thymoma

NCT05104736 2026-05-12

PT-112 in Subjects With Thymoma and Thymic Carcinoma

Phase 2 Recruiting

Thymic epithelial tumor, Peripheral Nervous System Diseases, Thymoma, Thymus Neoplasms

NCT06019468 2026-05-08

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Phase 2 Recruiting

Thymoma

NCT07324629 2026-05-07

Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma

Phase 2 Not yet recruiting

Thymoma

NCT04417660 2026-04-07

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

Phase 2 Active not recruiting

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT03463460 2026-03-23

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Phase 2 Active not recruiting

Thymoma

NCT07479628 2026-03-18

Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma

Phase 2 Not yet recruiting

Thymoma

NCT07132918 2026-03-11

HEARTS Trial for Thoracic Cancers

Phase 2 Recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Thymoma

NCT04710628 2026-02-19

PECATI

Phase 2 Completed

Thymoma

NCT06248515 2026-01-27

A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

Phase 2 Recruiting

Thymoma

NCT01025089 2026-01-07

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Phase 2 Active not recruiting

Thymoma

NCT06838910 2025-12-01

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

Phase 2 Recruiting

Thymoma

NCT03694002 2025-10-30

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

Phase 2 Completed

21 enrolled 17 charts

Thymoma

NCT06790706 2025-10-06

IMMUNORARE5

Phase 2 Recruiting

EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

NCT06186726 2025-06-13

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Phase 2 Recruiting

Thymoma

NCT06730308 2024-12-12

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

Phase 2 Recruiting

Thymoma

NCT01306045 2024-10-01

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

Phase 2 Completed

647 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma

NCT01621568 2024-09-24

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

Phase 2 Completed

56 enrolled 15 charts

Thymoma, Thymus Neoplasms

NCT04321330 2024-06-11

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

Phase 2 Completed

Thymoma

NCT03921671 2024-05-29

RELEVENT

Phase 2 Unknown

Neoplasm Metastasis, Thymoma

NCT04925947 2024-04-16

A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

Phase 2 Terminated

4 enrolled 10 charts

Thymoma

NCT04469725 2024-03-12

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Phase 2 Terminated

Thymoma

NCT05832827 2023-10-23

Artemis

Phase 2 Recruiting

Thymoma

NCT00010257 2023-06-29

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

Phase 2 Completed

46 enrolled 7 charts

Thymoma

NCT00003283 2023-06-15

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Phase 2 Completed

Thymoma

NCT05816694 2023-04-18

The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

Phase 2 Unknown

Thymoma

NCT03193437 2023-02-16

SELECT

Phase 2 Terminated

8 enrolled 11 charts

Thymoma

NCT02049047 2022-09-10

ONC-2010-001

Phase 2 Completed

Thymoma

NCT02307500 2022-09-10

RESOUND

Phase 2 Completed

DermatologicGastrointestinalGynecologicSarcomaThoracic

Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Thymoma

NCT05407649 2022-06-07

Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours

Phase 2 Unknown

Thymoma

NCT02220855 2022-04-11

A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas

Phase 2 Completed

14 enrolled 14 charts

Thymoma

NCT03663764 2021-12-10

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Phase 2 Unknown

Thymoma

NCT03449173 2021-06-09

Style

Phase 2 Unknown

Thymoma

NCT00024076 2020-08-03

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Thymoma, Small Cell Lung Carcinoma

NCT02364076 2019-12-13

Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma

Phase 2 Unknown

45 enrolled 10 charts

Thymoma, Thymus Neoplasms

NCT02062632 2019-10-01

Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy

Phase 2 Terminated

5 enrolled 4 charts

GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lymphoma, Mesothelioma, Sarcoma, Thymoma, Thyroid Neoplasms, Small Cell Lung Carcinoma

NCT00198133 2019-07-22

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma

Phase 2 Completed

27 enrolled 11 charts

Thymoma

NCT01364727 2019-04-16

A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies

Phase 2 Completed

33 enrolled 11 charts

Thymoma, Thymus Neoplasms

NCT01011439 2019-02-06

Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma

Phase 2 Terminated

72 enrolled 20 charts

Thymoma

NCT01301391 2019-02-06

Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy

Phase 2 Terminated

30 enrolled 19 charts

Thymoma

NCT02623127 2019-01-23

KOSMIC

Phase 2 Completed

Neoplasm Metastasis, Recurrence, Thymoma

NCT01610544 2018-07-05

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Hyperplasia, Thymoma, Thymus Neoplasms

NCT03466827 2018-03-15

TET-SEL

Phase 2 Unknown

Thymoma

NCT00332969 2017-03-31

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

Phase 2 Completed

Disease, Neoplasms, Thymoma

NCT00965250 2016-12-23

Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Phase 2 Completed

49 enrolled 20 charts

Thymoma

NCT00154388 2016-11-18

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Phase 2 Completed

BreastDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Malignant mesenchymal tumor, Adenocarcinoma, Brenner Tumor, Carcinoma, Renal Cell, Chondrosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Hemangiopericytoma, Hemangiosarcoma, Leiomyosarcoma, Leukemia, Mast-Cell, Liposarcoma, Mastocytosis, Melanoma, Mesothelioma, Multiple Myeloma, Pleural Neoplasms, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Thymoma, Hypereosinophilic Syndrome, Sarcoma, Endometrial Stromal, Dermatofibrosarcoma, Rhabdomyosarcoma, Embryonal, Seminoma, Carcinoma, Ductal, Breast, Neurofibrosarcoma, Primary Myelofibrosis, Small Cell Lung Carcinoma

NCT00589290 2015-09-30

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Phase 2 Completed

41 enrolled 8 charts

Mediastinal Neoplasms, Thymoma

NCT00718809 2015-06-10

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Phase 2 Terminated

21 enrolled 13 charts

Thymoma

NCT00387868 2014-12-09

Preoperative Treatment of Patients With High Risk Thymoma

Phase 2 Completed

Thymoma